![]() Stamatis G, Leschber G, Schwarz B, Brintrup DL, Ose C, Weinreich G, et al. Does segmentectomy really preserve the pulmonary function better than lobectomy for patients with early-stage lung cancer? Surg Today. Suzuki H, Morimoto J, Mizobuchi T, Fujiwara T, Nagato K, Nakajima T, et al. Computed tomography-defined functional lung volume after segmentectomy versus lobectomy. Ueda K, Tanaka T, Hayashi M, Li TS, Tanaka N, Hamano K. Evaluation of the residual lung function after thoracoscopic segmentectomy compared with lobectomy. Tane S, Nishio W, Nishioka Y, Tanaka H, Ogawa H, Kitamura Y, et al. Postoperative pulmonary function after complex segmentectomy. Handa Y, Tsutani Y, Mimae T, Miyata Y, Okada M. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. ![]() Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. Suzuki K, Watanabe SI, Wakabayashi M, Saji H, Aokage K, Moriya Y, et al. The correlation between PF and PROs was found to be weak therefore, further studies are needed to improve the patient’s postoperative experience. Wedge resection mitigated dyspnea in both cohorts. Sublobar resection preserved PF more than lobectomy did. Improvement of emotional and social function scores was independent of PF. Absolute correlation coefficient values ranged from 0.149 to 0.311. ![]() In addition to dyspnea, changes in PF were also correlated with scores for global health status, physical and role function scores, fatigue, nausea and vomiting, pain, and financial difficulties. ResultsĬohorts 1 and 2 comprised 206 and 149 patients, respectively. We set two cohorts: patients under the ongoing protocol (Cohort 1) and patients who were eligible for lobectomy with clinical stage I lung cancer (Cohort 2). Changes were calculated by subtracting the value at Pre from the value at Y1. The patients underwent PF tests and PRO assessments preoperatively (Pre) and 1 year after surgery (Y1). We recruited 262 patients who underwent lung resection for lung cancer, to evaluate the PROs, using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 and the Lung Cancer 13-question supplement (LC13). To investigate the relationship between changes in pulmonary function (PF) and patient-reported outcomes (PROs) of lung cancer surgery.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |